ELIGLUSTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eliglustat, and when can generic versions of Eliglustat launch?
Eliglustat is a drug marketed by Aizant, Apotex, Cipla, Dr Reddys, Teva Pharms Usa Inc, and Upsher Smith Labs. and is included in six NDAs.
The generic ingredient in ELIGLUSTAT is eliglustat tartrate. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eliglustat tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eliglustat
A generic version of ELIGLUSTAT was approved as eliglustat tartrate by AIZANT on September 8th, 2021.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ELIGLUSTAT?
- What are the global sales for ELIGLUSTAT?
- What is Average Wholesale Price for ELIGLUSTAT?
Summary for ELIGLUSTAT
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| DailyMed Link: | ELIGLUSTAT at DailyMed |
US Patents and Regulatory Information for ELIGLUSTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aizant | ELIGLUSTAT TARTRATE | eliglustat tartrate | CAPSULE;ORAL | 212463-001 | Sep 8, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Dr Reddys | ELIGLUSTAT TARTRATE | eliglustat tartrate | CAPSULE;ORAL | 212449-001 | Aug 17, 2022 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apotex | ELIGLUSTAT TARTRATE | eliglustat tartrate | CAPSULE;ORAL | 212425-001 | Jul 10, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cipla | ELIGLUSTAT TARTRATE | eliglustat tartrate | CAPSULE;ORAL | 212369-001 | Dec 10, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
